Wegovy now in Canada: Who should (and shouldn’t) use the weight-loss drug – GLOBAL

May 6, 2024

After years of persistent shortages, Canadians can now access Wegovy, an on-label weight loss medication, made by the same manufacturers of Ozempic.

Novo Nordisk’s drug officially hit the shelves on Monday, marking its availability despite being greenlit in Canada since 2021. Wegovy’s arrival holds promise for those battling obesity and diabetes.

Yet, as excitement brews, questions about its differences from medications like Ozempic, its ideal candidates and potential side effects may arise.

“This is a medical treatment approved for and studied in people living with a medical condition, obesity,” Dr. Sanjeev Sockalingam of Obesity Canada told Global News.

“In addition to losing weight to improve health, we also have evidence that [Wegovy] improves and reduces cardiovascular events in people who have had a previous history as well.”

Read more: https://globalnews.ca/news/10476494/wegovy-drug-canada-weight-loss-drug/